HLA/NN
binding/NN
characteristics/NNS
and/CC
generation/NN
of/IN
cytotoxic/JJ
lymphocytes/NNS
against/IN
peptides/NNS
derived/VBN
from/IN
oncogenic/JJ
proteins/NNS
./.

AIMS/NNS
AND/CC
BACKGROUND/NN
:/:
Structurally/RB
altered/VBN
proteins/NNS
(/(
derived/VBN
from/IN
chromosomal/JJ
translocations/NNS
or/CC
gene/NN
mutations/NNS
)/)
can/MD
be/VB
considered/VBN
tumor/NN
specific/JJ
antigens/NNS
and/CC
represent/VB
an/DT
attractive/JJ
target/NN
for/IN
a/DT
T-cell/NN
mediated/JJ
response/NN
./.
=====
T/NN
lymphocytes/NNS
recognize/VBP
antigens/NNS
in/IN
the/DT
form/NN
of/IN
peptides/NNS
bound/VBN
to/TO
HLA-molecules/NNS
./.
=====
MATERIALS/NNS
AND/CC
METHODS/NNS
:/:
Peptides/NNS
derived/VBN
from/IN
oncogenic/JJ
proteins/NNS
were/VBD
screened/VBN
for/IN
the/DT
presence/NN
of/IN
HLA/NN
binding/NN
motifs/NNS
;/:
actual/JJ
binding/NN
were/VBD
evaluated/VBN
by/IN
HLA/NN
stabilization/NN
experiments/NNS
using/VBG
transfectants/NNS
and/CC
specific/JJ
anti-HLA/JJ
antibodies/NNS
./.
=====
Specific/JJ
lymphocytes/NNS
were/VBD
induced/VBN
by/IN
in/FW
vitro/FW
peptide/NN
sensitization/NN
and/CC
screened/VBN
by/IN
thymidine/NN
uptake/NN
or/CC
cellular/JJ
cytotoxic/JJ
assays/NNS
./.
=====
RESULTS/NNS
:/:
We/PRP
identified/VBD
peptides/NNS
derived/VBN
from/IN
EWS/FLI-1/NN
fusion/NN
protein/NN
and/CC
from/IN
mutated/VBN
K-RAS/NN
protein/NN
(/(
encompassing/VBG
respectively/RB
the/DT
fusion/NN
point/NN
and/CC
the/DT
mutation/NN
at/IN
position/NN
12/CD
)/)
that/WDT
showed/VBD
binding/VBG
motif/NN
for/IN
HLA-Cw*0702/NN
and/CC
HLA-A3/NN
respectively/RB
./.
=====
The/DT
actual/JJ
binding/NN
of/IN
these/DT
peptides/NNS
was/VBD
analysed/VBN
in/IN
a/DT
stabilization/NN
assay/NN
./.
=====
We/PRP
detected/VBD
binding/NN
for/IN
the/DT
EWS/FLI-1/NN
peptide/NN
and/CC
for/IN
5/CD
RAS/NN
peptides/NNS
(/(
1/CD
wild/JJ
type/NN
and/CC
4/CD
mutated/VBN
)/)
./.
=====
The/DT
effect/NN
of/IN
temperature/NN
,/,
beta/NN
2-microglobulin/NN
(/(
beta/NN
2-m/NN
)/)
and/CC
fetal/JJ
calf/NN
serum/NN
(/(
FCS/NN
)/)
on/IN
the/DT
binding/NN
and/CC
the/DT
stability/NN
of/IN
the/DT
HLA/peptide/NN
complex/NN
was/VBD
studied/VBN
./.
=====
A/DT
low/JJ
temperature/NN
(/(
26/CD
degrees/NNS
C/NN
)/)
increased/VBD
the/DT
binding/NN
both/CC
in/IN
HLA-A3/NN
and/CC
HLA-Cw*0702/NN
,/,
while/IN
FCS/NN
reduced/VBD
it/PRP
./.
=====
beta/NN
2-m/NN
increased/VBD
the/DT
binding/NN
to/TO
the/DT
HLA-A3/NN
molecule/NN
but/CC
did/VBD
not/RB
influence/VB
the/DT
binding/NN
to/TO
the/DT
HLA-Cw*0702/NN
./.
=====
The/DT
stability/NN
of/IN
already/RB
formed/VBN
complexed/VBN
was/VBD
somewhat/RB
different/JJ
in/IN
the/DT
HLA-A3/NN
and/CC
HLA-Cw*0702/NN
system/NN
:/:
both/DT
were/VBD
more/RBR
stable/JJ
at/IN
26/CD
degrees/NNS
C/NN
than/IN
at/IN
37/CD
degrees/NNS
C/NN
but/CC
while/IN
the/DT
beta/NN
2-m/NN
and/CC
FCS/NN
did/VBD
not/RB
influence/VB
the/DT
stability/NN
of/IN
the/DT
HLA-A3/peptide/NN
complex/NN
,/,
they/PRP
seemed/VBD
to/TO
cause/VB
opposite/JJ
effects/NNS
in/IN
the/DT
HLA-Cw*0702/NN
system/NN
(/(
beta/NN
2-m/NN
stabilized/VBD
and/CC
FCS/NN
destabilized/VBD
the/DT
complex/NN
)/)
./.
=====
Finally/RB
,/,
we/PRP
were/VBD
able/JJ
to/TO
generate/VB
a/DT
specific/JJ
CD8+/JJ
CTL/NN
line/NN
against/IN
a/DT
K-RAS/NN
mutated/JJ
peptide/NN
./.
=====
CONCLUSIONS/NNS
:/:
Although/IN
binding/VBG
motifs/NNS
and/CC
actual/JJ
HLA/NN
binding/NN
can/MD
be/VB
detected/VBN
in/IN
several/JJ
cases/NNS
,/,
the/DT
generation/NN
of/IN
a/DT
cellular/JJ
response/NN
is/VBZ
infrequent/JJ
,/,
confirming/VBG
that/IN
HLA/NN
binding/NN
is/VBZ
necessary/JJ
but/CC
not/RB
sufficient/JJ
to/TO
obtain/VB
an/DT
in/FW
vitro/FW
response/NN
./.
=====
Further/RB
optimization/NN
of/IN
culture/NN
conditions/NNS
,/,
type/NN
of/IN
Antigen/NN
Presenting/NN
Cells/NNS
(/(
APC/NNS
)/)
,/,
peptides/NNS
,/,
use/NN
of/IN
stabilizers/NNS
like/IN
beta/NN
2-m/NN
are/VBP
still/RB
needed/VBN
./.